Find the Perfect Plan for Your Investment Journey
G
Latest price
52 Week Range
CA$0.28 - CA$1.25
Next Earnings Date
May 30 2025 (Estimate)
Next Earnings Date
May 30 2025 (Est.)
Latest price
Market Cap | CA$74.97M |
EV | CA$76.39M |
Shares Outstanding | 80.52M |
Beta | 0.59 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E undefinedE | - |
P/Revenue undefinedE | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin undefinedE | - |
Net Profit Margin undefinedE | - |
ROE undefinedE | - |
ROCE | - |
DPS undefinedE | - |
Payout Ratio undefinedE | - |
Div. Yield undefinedE | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
G
Gemina Laboratories Ltd.
GLAB
Sector
Healthcare
Industry
Biotechnology
CEO
Firth, Brian
Employees
6
Website
www.geminalabs.comIPO Date
2021-08-12
Headquarters
3600 Gilmore Way, Unit 302, Burnaby, British Columbia, V5G 4W8, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved